PT UBC Medical Indonesia Tbk (IDX:LABS)

IDX:LABS Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6,865	41,165	42,554	3,617	827.53	11,598
Cash & Short-Term Investments	6,865	41,165	42,554	3,617	827.53	11,598
Cash Growth	-60.17%	-3.26%	1076.53%	337.07%	-92.86%	-
Receivables	52,192	32,928	19,585	33,326	17,015	7,438
Inventory	82,873	78,067	74,038	57,286	35,383	30,498
Prepaid Expenses	2,691	1,642	3,561	202.54	266.63	154.22
Other Current Assets	34,981	28,643	19,307	16,464	6,182	9,177
Total Current Assets	179,602	182,444	159,045	110,896	59,674	58,864
Property, Plant & Equipment	31,931	33,714	33,452	36,104	25,000	31,041
Long-Term Investments	-	-	-	-	5,952	2,430
Other Intangible Assets	3,769	4,411	5,339	6,147	-	-
Long-Term Deferred Tax Assets	4,299	4,299	2,897	2,734	3,158	2,565
Long-Term Deferred Charges	943.14	1,333	2,489	4,383	5,587	-
Other Long-Term Assets	2,801	1,987	376.6	23	1,174	93.44
Total Assets	223,346	228,187	203,599	160,287	108,730	94,994

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	39,264	45,478	26,463	38,474	35,041	32,022
Accrued Expenses	1,426	748.71	586.48	2,901	1,283	512.1
Short-Term Debt	22,512	24,736	23,973	21,322	18,563	24,000
Current Portion of Long-Term Debt	540.2	1,012	1,029	368.19	487.91	373.55
Current Portion of Leases	-	89.81	252.71	229.44	182.16	284.81
Current Income Taxes Payable	309.8	167.32	312	1,128	905.87	3,614
Current Unearned Revenue	-	-	-	6,926	-	9,282
Other Current Liabilities	96.38	36.1	6.97	18,831	4,020	13,732
Total Current Liabilities	64,148	72,268	52,623	90,179	60,482	83,820
Long-Term Debt	702.8	1,665	10,597	19,159	297.2	1,416
Long-Term Leases	-	-	89.81	342.52	-	-
Pension & Post-Retirement Benefits	1,791	1,791	1,535	1,246	480.26	525.58
Total Liabilities	66,641	75,723	64,845	110,927	61,260	85,761

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	79,000	79,000	79,000	46,837	46,837	11,432
Additional Paid-In Capital	54,157	54,157	54,157	-	-	-
Retained Earnings	22,969	18,728	5,221	2,269	79.02	-2,755
Comprehensive Income & Other	578.55	578.55	375.77	253.93	554.01	555.17
Total Common Equity	156,704	152,464	138,755	49,360	47,470	9,232
Minority Interest	0.07	0.06	0.1	0.08	1	-
Shareholders' Equity	156,704	152,464	138,755	49,360	47,471	9,232
Total Liabilities & Equity	223,346	228,187	203,599	160,287	108,730	94,994

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	23,755	27,503	35,941	41,422	19,530	26,074
Net Cash (Debt)	-16,890	13,662	6,612	-37,805	-18,703	-14,477
Net Cash Growth	-	106.61%	-	-	-	-
Net Cash Per Share	-4.28	3.46	1.67	-16.06	-	-
Filing Date Shares Outstanding	3,950	3,950	3,950	3,250	-	-
Total Common Shares Outstanding	3,950	3,950	3,950	3,250	-	-
Working Capital	115,454	110,176	106,422	20,717	-807.81	-24,956
Book Value Per Share	39.67	38.60	35.13	15.19	-	-
Tangible Book Value	152,936	148,053	133,415	43,213	47,470	9,232
Tangible Book Value Per Share	38.72	37.48	33.78	13.30	-	-
Buildings	4,355	4,355	4,355	4,096	-	-
Machinery	91,152	87,421	78,786	70,293	54,282	52,385

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error